18 February 2025
Euronext publishes Q4 and full year 2024 results Euronext delivered double-digit revenue growth in 2024 thanks to its diversified revenue profile and confirms the…
17 February 2025
Penmenvy, GSK’s 5-in-1 meningococcal vaccine, approved by US FDA to help protect against MenABCWY GSK plc (LSE/NYSE: GSK) today announced that the US Food and…
13 February 2025
The Scottish American Investment Company P.L.C. Legal Entity Identifier: 549300NF03XVC5IFB447 Regulated Information Classification: Additional regulated information required to be disclosed under the applicable laws…
13 February 2025 Concurrent Technologies Plc (the “Company” or the “Group”) Commencement of Trading on OTCQX in the U.S. Concurrent Technologies Plc (AIM: CNC),…
Renishaw plc 13 February 2025 Interim report for the six months ended 31 December 2024 (H1 FY2025) Steady progress in…
2024 Full Year Results Improved performance led by volume growth and gross margin expansion Underlying performance GAAP measures (unaudited) 2024 vs 2023…
12 February 2025
KEY HIGHLIGHTS Dolf van den Brink, Chairman of the Executive Board / CEO said: “We delivered solid results with broad-based growth and profit expansion…
RUFFER INVESTMENT COMPANY LIMITED (the “Company“) Portfolio Manager Changes The Board of Ruffer Investment Company (the Company) has been notified by Ruffer LLP (“Ruffer”)…